DRUG · Mapped RxNorm record
Tirzepatide
Normalized identity: tirzepatideView linked drug · Find medicine records ·
Find other trials using this name
Clinical trial
A Study of Tirzepatide in Overweight and Very Overweight Participants
NCT04311411
Drugs and interventions used in this trial
3 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
DRUG · Unmapped registry intervention
Placebo
Find medicine records ·
Find other trials using this name
DRUG · Mapped RxNorm record
Liraglutide
Normalized identity: liraglutideView linked drug · Find medicine records ·
Find other trials using this name
No matching interventions in this trial.
Study at a glance
Registry-backedA Study of Tirzepatide in Overweight and Very Overweight Participants
Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE1
Read study objectives, eligibility and outcome measures at ClinicalTrials.govAdvertisement
Conditions
Obesityverified · MONDO: obesity disorder
Overweightunresolved
Interventions
TirzepatideDRUG · verified · RxNorm: tirzepatide
PlaceboDRUG
LiraglutideDRUG · verified · RxNorm: liraglutide
Sponsors & collaborators
Eli Lilly and Companylead sponsor
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT04311411 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.